News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
91,002 Results
Type
Article (5942)
Company Profile (20)
Press Release (85040)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (26050)
Career Advice (133)
Deals (3532)
Drug Delivery (7)
Drug Development (11687)
Employer Resources (4)
FDA (1992)
Job Trends (1619)
News (42853)
Policy (3118)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Standard (1)
Academia (615)
Academic (1)
Adcomms (4)
Allergies (6)
Alliances (9259)
ALS (27)
Alzheimer's disease (601)
Antibody-drug conjugate (ADC) (14)
Approvals (1983)
Artificial intelligence (69)
Autoimmune disease (4)
Automation (2)
Bankruptcy (17)
Best Places to Work (1424)
BIOSECURE Act (1)
Biosimilars (7)
Biotechnology (15)
Bladder cancer (20)
Brain cancer (10)
Breast cancer (76)
Cancer (558)
Cardiovascular disease (16)
Career advice (119)
Career pathing (4)
CAR-T (9)
Cell therapy (39)
Cervical cancer (6)
Clinical research (8565)
Collaboration (182)
Compensation (13)
COVID-19 (440)
CRISPR (3)
C-suite (44)
Cystic fibrosis (11)
Data (430)
Denatured (1)
Depression (4)
Diabetes (27)
Diagnostics (3029)
Digital health (2)
Diversity (1)
Drug discovery (30)
Drug pricing (2)
Drug shortages (1)
Duchenne muscular dystrophy (10)
Earnings (6772)
Editorial (3)
Employer branding (1)
Employer resources (3)
Events (11618)
Executive appointments (100)
FDA (2151)
Featured Employer (6)
Frontotemporal dementia (5)
Funding (115)
Gene editing (12)
Generative AI (7)
Gene therapy (41)
GLP-1 (79)
Government (484)
Guidances (4)
Healthcare (2352)
Huntington's disease (5)
IgA nephropathy (5)
Immunology and inflammation (22)
Indications (3)
Infectious disease (462)
Inflammatory bowel disease (22)
Influenza (13)
Intellectual property (10)
Interviews (13)
IPO (1290)
IRA (1)
Job creations (251)
Job search strategy (109)
Kidney cancer (2)
Layoffs (21)
Leadership (1)
Legal (425)
Liver cancer (12)
Lung cancer (88)
Lymphoma (25)
Management (2)
Manufacturing (24)
MASH (8)
Medical device (969)
Medtech (969)
Mergers & acquisitions (2295)
Metabolic disorders (68)
Multiple sclerosis (16)
Neurodegenerative disease (22)
Neuropsychiatric disorders (2)
Neuroscience (710)
NextGen: Class of 2025 (556)
Non-profit (509)
Northern California (371)
Now hiring (6)
Obesity (33)
Opinion (17)
Ovarian cancer (8)
Pain (14)
Pancreatic cancer (15)
Parkinson's disease (34)
Partnered (2)
Patents (23)
Patient recruitment (9)
Peanut (2)
People (8967)
Pharmaceutical (3)
Phase I (3193)
Phase II (3918)
Phase III (2500)
Pipeline (170)
Policy (4)
Postmarket research (240)
Preclinical (2171)
Press Release (18)
Prostate cancer (22)
Psychedelics (2)
Radiopharmaceuticals (56)
Rare diseases (46)
Real estate (639)
Recruiting (1)
Regulatory (2467)
Reports (6)
Research institute (695)
Resumes & cover letters (16)
RNA editing (3)
RSV (1)
Schizophrenia (6)
Series A (21)
Series B (9)
Service/supplier (1)
Sickle cell disease (5)
Southern California (240)
Spinal muscular atrophy (31)
Sponsored (4)
Startups (618)
Supply chain (4)
Tariffs (1)
The Weekly (3)
United States (2981)
Vaccines (48)
Venture capitalists (1)
Weight loss (14)
Women's health (1)
Worklife (1)
Date
Today (12)
Last 7 days (108)
Last 30 days (389)
Last 365 days (4863)
2025 (1504)
2024 (5110)
2023 (6014)
2022 (8670)
2021 (8605)
2020 (7470)
2019 (5289)
2018 (3873)
2017 (4769)
2016 (4612)
2015 (5634)
2014 (3941)
2013 (3299)
2012 (3466)
2011 (3615)
2010 (3031)
Location
Africa (70)
Alabama (3)
Alaska (1)
Arizona (29)
Arkansas (1)
Asia (4904)
Australia (1119)
California (773)
Canada (212)
China (87)
Colorado (22)
Connecticut (34)
Delaware (20)
Europe (16970)
Florida (82)
Georgia (7)
Idaho (7)
Illinois (64)
India (5)
Indiana (32)
Iowa (1)
Japan (29)
Kansas (2)
Kentucky (1)
Maine (5)
Maryland (90)
Massachusetts (647)
Michigan (26)
Minnesota (43)
Missouri (15)
Montana (2)
Nevada (1)
New Hampshire (6)
New Jersey (193)
New Mexico (16)
New York (284)
North Carolina (82)
North Dakota (4)
Northern California (371)
Ohio (26)
Oklahoma (1)
Oregon (3)
Pennsylvania (180)
Rhode Island (4)
South America (108)
Southern California (240)
Tennessee (6)
Texas (197)
Utah (58)
Virginia (19)
Washington D.C. (6)
Washington State (81)
Wisconsin (8)
91,002 Results for "targos molecular pathology gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BostonGene to Showcase AI-Driven Molecular Profiling Solutions at the Association for Molecular Pathology 2024 Annual Meeting
November 21, 2024
·
3 min read
Collaboration
Lilly Hops On Hot Molecular Glue Train With $1.2B+ Magnet Deal
The molecular glue space has attracted several Big Pharma players over the past few years, including Novo Nordisk, Pfizer and Novartis.
February 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH
March 19, 2025
·
1 min read
Press Releases
Sirona Biochem Secures Strategic Investment Agreements and New Joint Venture with Promura GmbH
April 22, 2025
·
6 min read
Press Releases
Precision for Medicine and Agena Bioscience Announce Strategic Partnership and Breakthrough Findings at Association for Molecular Pathology 2024 Annual Meeting & Expo
November 20, 2024
·
4 min read
Drug Development
Molecular Glue Degraders at Inflection Point as Pharma Dives In
Novartis, Biogen, Takeda and Novo Nordisk are all betting on advances in the molecular glue degraders space, collectively investing billions in hopes of treating cancer, Alzheimer’s disease, cardiometabolic disease and more.
December 16, 2024
·
6 min read
·
Kate Goodwin
Press Releases
The Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) Selects Indica Labs’ HALO AP to Deliver AI-enabled Diagnostics
October 31, 2024
·
4 min read
Press Releases
ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology
April 21, 2025
·
3 min read
Press Releases
T-CURX GmbH Enters into Technology Access Agreement with Kytopen
February 14, 2025
·
5 min read
Press Releases
Labcorp Launches Molecular Residual Disease and Liquid Biopsy Solutions
April 24, 2025
·
4 min read
1 of 9,101
Next
